DK1893597T3 - AMPA-receptorpotentiatorer - Google Patents
AMPA-receptorpotentiatorerInfo
- Publication number
- DK1893597T3 DK1893597T3 DK06771143T DK06771143T DK1893597T3 DK 1893597 T3 DK1893597 T3 DK 1893597T3 DK 06771143 T DK06771143 T DK 06771143T DK 06771143 T DK06771143 T DK 06771143T DK 1893597 T3 DK1893597 T3 DK 1893597T3
- Authority
- DK
- Denmark
- Prior art keywords
- ampa receptor
- receptor potentiators
- potentiators
- ampa
- formulations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05380117 | 2005-06-06 | ||
EP05380187 | 2005-08-18 | ||
US72420605P | 2005-10-06 | 2005-10-06 | |
PCT/US2006/020204 WO2006132811A2 (en) | 2005-06-06 | 2006-05-25 | Ampa receptor potentiators |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1893597T3 true DK1893597T3 (da) | 2009-01-19 |
Family
ID=43268739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06771143T DK1893597T3 (da) | 2005-06-06 | 2006-05-25 | AMPA-receptorpotentiatorer |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1893597B1 (da) |
KR (1) | KR100975995B1 (da) |
AT (1) | ATE414073T1 (da) |
AU (1) | AU2006255709B2 (da) |
BR (1) | BRPI0611353A2 (da) |
CA (1) | CA2611609C (da) |
DK (1) | DK1893597T3 (da) |
EA (1) | EA012310B1 (da) |
ES (1) | ES2314932T3 (da) |
NZ (1) | NZ562631A (da) |
PL (1) | PL1893597T3 (da) |
PT (1) | PT1893597E (da) |
SI (1) | SI1893597T1 (da) |
TN (1) | TNSN07462A1 (da) |
TW (2) | TW201431849A (da) |
WO (1) | WO2006132811A2 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0602560D0 (en) * | 2006-02-08 | 2006-03-22 | Glaxo Group Ltd | Compounds |
US20100035865A1 (en) * | 2007-04-03 | 2010-02-11 | Pfizer Inc | Sulfonamides and Pharmaceutical Compositions Thereof |
TWI644899B (zh) | 2013-02-04 | 2018-12-21 | 健生藥品公司 | Flap調節劑 |
EP3495359A1 (en) * | 2013-02-04 | 2019-06-12 | Janssen Pharmaceutica NV | Flap modulators |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5151684A (en) | 1991-04-12 | 1992-09-29 | Johnsen Edward L | Electronic inventory label and security apparatus |
CA2212829A1 (en) * | 1995-02-21 | 1996-08-29 | Jiro Takeo | Glutamic acid receptor agonist |
US6269342B1 (en) | 1995-04-28 | 2001-07-31 | Telxon Corporation | Programmable shelf tag system |
AU4220399A (en) | 1998-05-29 | 1999-12-13 | Tagcorp., Inc. | Remote controlled electronic price tag |
US6307919B1 (en) | 1998-05-29 | 2001-10-23 | Yehuda Yoked | Remote controlled electronic price tag |
US6753830B2 (en) | 1998-09-11 | 2004-06-22 | Visible Tech-Knowledgy, Inc. | Smart electronic label employing electronic ink |
GB2356108A (en) | 1999-11-03 | 2001-05-09 | Motorola Israel Ltd | Anti-theft shopping tag with display |
WO2002063602A1 (en) | 2001-02-07 | 2002-08-15 | Visible Tech-Knowledgy, Llc | Smart electronic label employing electronic ink |
WO2002098847A1 (en) * | 2001-05-30 | 2002-12-12 | Eli Lilly And Company | Cycloalkenylsulfonamide derivatives |
US20030092770A1 (en) | 2002-10-23 | 2003-05-15 | Phil Skolnick | Combination therapy for treatment of depression |
ATE430729T1 (de) * | 2003-10-08 | 2009-05-15 | Lilly Co Eli | Pyrrol- und pyrazolderivate als potentiatoren von glutamatrezeptoren |
US7520429B2 (en) | 2004-03-31 | 2009-04-21 | United Parcel Service Of America, Inc. | Systems and methods for an electronic programmable merchandise tag |
WO2006015827A1 (en) * | 2004-08-09 | 2006-02-16 | Glaxo Group Limited | Compounds which potentiate glutamate receptor and uses thereof in medicine |
US7178727B2 (en) | 2005-01-26 | 2007-02-20 | Tagcorp, Inc. | Remote controlled separable electronic price tag |
-
2006
- 2006-05-11 TW TW103117042A patent/TW201431849A/zh unknown
- 2006-05-11 TW TW095116654A patent/TWI446908B/zh not_active IP Right Cessation
- 2006-05-25 WO PCT/US2006/020204 patent/WO2006132811A2/en active Application Filing
- 2006-05-25 BR BRPI0611353-2A patent/BRPI0611353A2/pt not_active IP Right Cessation
- 2006-05-25 CA CA2611609A patent/CA2611609C/en not_active Expired - Fee Related
- 2006-05-25 PT PT06771143T patent/PT1893597E/pt unknown
- 2006-05-25 ES ES06771143T patent/ES2314932T3/es active Active
- 2006-05-25 PL PL06771143T patent/PL1893597T3/pl unknown
- 2006-05-25 AT AT06771143T patent/ATE414073T1/de active
- 2006-05-25 EA EA200702618A patent/EA012310B1/ru not_active IP Right Cessation
- 2006-05-25 KR KR1020077028411A patent/KR100975995B1/ko not_active IP Right Cessation
- 2006-05-25 SI SI200630176T patent/SI1893597T1/sl unknown
- 2006-05-25 AU AU2006255709A patent/AU2006255709B2/en not_active Ceased
- 2006-05-25 DK DK06771143T patent/DK1893597T3/da active
- 2006-05-25 EP EP06771143A patent/EP1893597B1/en active Active
- 2006-05-25 NZ NZ562631A patent/NZ562631A/en not_active IP Right Cessation
-
2007
- 2007-12-05 TN TNP2007000462A patent/TNSN07462A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2006255709B2 (en) | 2011-10-06 |
EP1893597A2 (en) | 2008-03-05 |
ES2314932T3 (es) | 2009-03-16 |
PT1893597E (pt) | 2009-01-13 |
EA012310B1 (ru) | 2009-08-28 |
SI1893597T1 (sl) | 2009-04-30 |
ATE414073T1 (de) | 2008-11-15 |
CA2611609A1 (en) | 2006-12-14 |
WO2006132811A2 (en) | 2006-12-14 |
TW201431849A (zh) | 2014-08-16 |
AU2006255709A1 (en) | 2006-12-14 |
TW200718419A (en) | 2007-05-16 |
KR20080024474A (ko) | 2008-03-18 |
PL1893597T3 (pl) | 2009-04-30 |
KR100975995B1 (ko) | 2010-08-17 |
TWI446908B (zh) | 2014-08-01 |
BRPI0611353A2 (pt) | 2010-12-07 |
WO2006132811A3 (en) | 2007-02-01 |
TNSN07462A1 (en) | 2009-03-17 |
NZ562631A (en) | 2011-01-28 |
EP1893597B1 (en) | 2008-11-12 |
EA200702618A1 (ru) | 2008-04-28 |
CA2611609C (en) | 2013-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200740814A (en) | Compounds | |
TNSN07195A1 (en) | Potentiators of glutamate receptors | |
TW200624426A (en) | BACE inhibitors | |
TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
DE602005021696D1 (de) | Indazolcarbonsäureamidverbindungen | |
DE602005014566D1 (de) | Chinolinon-carboxamid-verbindungen | |
ATE441646T1 (de) | 5-ht4-rezeptoragonistenverbindungen | |
EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
WO2007072201A3 (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
ATE417849T1 (de) | Pyrazoloä4,3-düpyrimidine | |
EA200801549A1 (ru) | Новые производные фенантридина в качестве антагонистов брадикинина | |
CY1108718T1 (el) | Ενισχυται υποδοχεως αμρα | |
DK1893597T3 (da) | AMPA-receptorpotentiatorer | |
EA200702428A1 (ru) | Способы получения 4-бифенилилазетидин-2-онов | |
WO2008107771A3 (en) | 2',3'-di-o-acyl-5-fluoronucleosides | |
DE602007005387D1 (de) | Ptors | |
UA92343C2 (en) | Ampa receptor potentiators | |
CR9578A (es) | Inhibidores de la adenilato ciclasa soluble | |
ATE425212T1 (de) | Tocopherolzusammensetzungen und verwendung | |
CY1106649T1 (el) | Νεα 1-μεθοξυ-2-φαινυλ-αιθενια χρησιμα δια την παρασκευην 5-καρβοξαλδεϋδο-2,3-διϋδροβενζοξεπινων | |
DOP2006000089A (es) | Derivados de tetrahidronaftalina, procedimientos para su preparacion y uso como antiinflamatorios. | |
DOP2005000180A (es) | Inhibidores bace |